ANAPTYSBIO INC

Organization

SANDIEGO, CA, US

Ticker Symbols

NASDAQ:ANAB

PHARMACEUTICAL PREPARATIONS
Business Address
10421 PACIFIC CENTER COURT, SUITE 200 SAN DIEGO CA 92121 858-362-6295
Mailing Address
10421 PACIFIC CENTER COURT, SUITE 200 SAN DIEGO CA 92121
State Location
CA
State of Incorporation
DE

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Method of treating autoimmune disease with antibodies against IL-33
- Patent number 11,999,783
- Issue date Jun 4, 2024
- AnaptysBio, Inc.
- Robert A. Horlick
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies directed against T cell immunoglobulin and mucin protein...
- Patent number 11,753,472
- Issue date Sep 12, 2023
- Tesaro, Inc.
- David J. King
- Y02 - TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMA...
Information Patent Grant
Antibodies directed against T Cell immunoglobulin and mucin protein...
- Patent number 11,352,427
- Issue date Jun 7, 2022
- AnaptysBio, Inc.
- Marilyn Kehry
- Y02 - TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMA...
Information Patent Grant
Antibodies directed against programmed death-1 (PD-1)
- Patent number 11,155,624
- Issue date Oct 26, 2021
- AnaptysBio, Inc.
- David J. King
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Method of treating pustular psoriasis with antibodies directed agai...
- Patent number 11,130,814
- Issue date Sep 28, 2021
- AnaptysBio, Inc.
- Peter Bowers
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Method of treating inflammatory disorder with antibodies directed a...
- Patent number 10,836,820
- Issue date Nov 17, 2020
- AnaptysBio, Inc.
- Robert A. Horlick
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies directed against lymphocyte activation gene 3 (LAG-3)
- Patent number 10,836,824
- Issue date Nov 17, 2020
- AnaptysBio, Inc.
- Helen Toni Jun
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies directed against programmed death-1 (PD-1)
- Patent number 10,738,117
- Issue date Aug 11, 2020
- AnaptysBio, Inc.
- David J. King
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies directed against interleukin 36 receptor (IL-36R)
- Patent number 10,526,410
- Issue date Jan 7, 2020
- AnaptysBio, Inc.
- Peter Bowers
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies directed against T cell immunoglobulin and mucin protein...
- Patent number 10,508,149
- Issue date Dec 17, 2019
- AnaptysBio, Inc.
- Marilyn Kehry
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies directed against interleukin-33 (IL-33) and methods of m...
- Patent number 10,059,764
- Issue date Aug 28, 2018
- AnaptysBio, Inc.
- Robert A. Horlick
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies directed against nerve growth factor (NGF)
- Patent number 9,951,126
- Issue date Apr 24, 2018
- AnaptysBio, Inc.
- David J. King
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies directed against programmed death-1 (PD-1)
- Patent number 9,815,897
- Issue date Nov 14, 2017
- AnaptysBio, Inc.
- David J. King
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of generating libraries and uses thereof
- Patent number 9,637,556
- Issue date May 2, 2017
- AnaptysBio, Inc.
- Peter M. Bowers
- C40 - COMBINATORIAL CHEMISTRY
Information Patent Grant
Antibodies directed against IL-17
- Patent number 9,328,166
- Issue date May 3, 2016
- AnaptysBio, Inc.
- Robert Horlick
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods of generating libraries and uses thereof
- Patent number 9,260,533
- Issue date Feb 16, 2016
- AnaptysBio, Inc.
- Peter M. Bowers
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Humanized antibodies directed against complement protein C5
- Patent number 9,133,269
- Issue date Sep 15, 2015
- AnaptysBio, Inc.
- Audrey McConnell
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies directed against nerve growth factor (NGF)
- Patent number 8,926,978
- Issue date Jan 6, 2015
- AnaptysBio, Inc.
- David J. King
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of generating libraries and uses thereof
- Patent number 8,685,897
- Issue date Apr 1, 2014
- AnaptysBio, Inc.
- Peter M. Bowers
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods of generating libraries and uses thereof
- Patent number 8,603,950
- Issue date Dec 10, 2013
- AnaptysBio, Inc.
- Peter M. Bowers
- C07 - ORGANIC CHEMISTRY

Please log in for detailed analytics

Patents Applicationslast 30 patents

Information Patent Application
ANTIBODIES DIRECTED AGAINST INTERLEUKIN-33 (IL-33)
- Publication number 20240294631
- Publication date Sep 5, 2024
- ANAPTYSBIO, INC.
- Robert A. Horlick
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODY COMPOSITION
- Publication number 20240216506
- Publication date Jul 4, 2024
- ANAPTYSBIO, INC.
- Alex Praseuth
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Antibody Agents Directed Against Lymphocyte Activation Gene-3 (LAG-...
- Publication number 20240158495
- Publication date May 16, 2024
- Tesaro, Inc.
- Helen Toni Jun
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-INTERLEUKIN 36 RECEPTOR (IL-36R) THERAPY FOR HIDRADENITIS SUPP...
- Publication number 20240084021
- Publication date Mar 14, 2024
- ANAPTYSBIO, INC.
- Paul F. Lizzul
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Antibodies Directed Against T Cell Immunoglobulin and Mucin Protein...
- Publication number 20230416368
- Publication date Dec 28, 2023
- ANAPTYSBIO, INC.
- David J. King
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
B AND T LYMPHOCYTE ATTENUATOR (BTLA) MODULATORS AND METHOD OF USING...
- Publication number 20230391872
- Publication date Dec 7, 2023
- ANAPTYSBIO, INC.
- Martin Edward Dahl
- G01 - MEASURING TESTING
Information Patent Application
Antibodies Directed Against Programmed Death-1(PD-1)
- Publication number 20230331843
- Publication date Oct 19, 2023
- ANAPTYSBIO, INC.
- David J. King
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-INTERLEUKIN 36 RECEPTOR (IL-36R) THERAPY FOR ICHTHYOSIS
- Publication number 20230272092
- Publication date Aug 31, 2023
- ANAPTYSBIO, INC.
- Amy Paller
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PD-1 AGONIST AND METHOD OF USING SAME
- Publication number 20220235132
- Publication date Jul 28, 2022
- ANAPTYSBIO, INC.
- Marilyn KEHRY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES DIRECTED AGAINST T CELL IMMUNOGLOBULIN AND MUCIN PROTEIN...
- Publication number 20220169734
- Publication date Jun 2, 2022
- ANAPTYSBIO, INC.
- David J. King
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODY AGENTS DIRECTED AGAINST LYMPHOCYTE ACTIVATION GENE-3 (LAG-...
- Publication number 20220135670
- Publication date May 5, 2022
- Tesaro, Inc.
- Helen Toni Jun
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antibodies Directed Against Programmed Death-1 (PD-1)
- Publication number 20220089739
- Publication date Mar 24, 2022
- Tesaro, Inc.
- David J. King
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTIBODIES DIRECTED AGAINST INTERLEUKIN 36 RECEPTOR (IL-36R)
- Publication number 20210388095
- Publication date Dec 16, 2021
- ANAPTYSBIO, INC.
- Peter BOWERS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antibodies Directed Against Programmed Death-1(PD-1)
- Publication number 20210163589
- Publication date Jun 3, 2021
- ANAPTYSBIO, INC.
- David J. King
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antibodies Directed Against Lymphocyte Activation Gene 3 (LAG-3)
- Publication number 20210095026
- Publication date Apr 1, 2021
- ANAPTYSBIO, INC.
- Helen Toni JUN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES DIRECTED AGAINST INTERLEUKIN-33 (IL-33)
- Publication number 20210040198
- Publication date Feb 11, 2021
- ANAPTYSBIO, INC.
- Robert A. Horlick
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-IL-33 THERAPY FOR ATOPIC DERMATITIS
- Publication number 20200239562
- Publication date Jul 30, 2020
- ANAPTYSBIO, INC.
- Marco LONDEI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES DIRECTED AGAINST T CELL IMMUNOGLOBULIN AND MUCIN PROTEIN...
- Publication number 20200148770
- Publication date May 14, 2020
- ANAPTYSBIO, INC.
- Marilyn KEHRY
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES DIRECTED AGAINST INTERLEUKIN 36 RECEPTOR (IL-36R)
- Publication number 20200087408
- Publication date Mar 19, 2020
- ANAPTYSBIO, INC.
- Peter BOWERS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES DIRECTED AGAINST T CELL IMMUNOGLOBULIN AND MUCIN PROTEIN...
- Publication number 20190284280
- Publication date Sep 19, 2019
- ANAPTYSBIO, INC.
- David J. King
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES DIRECTED AGAINST LYMPHOCYTE ACTIVATION GENE 3 (LAG-3)
- Publication number 20190256596
- Publication date Aug 22, 2019
- ANAPTYSBIO, INC.
- Helen Toni JUN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES DIRECTED AGAINST PROGRAMMED DEATH- 1 (PD-1)
- Publication number 20190256600
- Publication date Aug 22, 2019
- ANAPTYSBIO, INC.
- David J. King
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INHIBITION OF ALLERGIC REACTION USING AN IL-33 INHIBITOR
- Publication number 20190016795
- Publication date Jan 17, 2019
- ANAPTYSBIO, INC.
- Marco LONDEI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES DIRECTED AGAINST INTERLEUKIN-33 (IL-33)
- Publication number 20180346562
- Publication date Dec 6, 2018
- ANAPTYSBIO, INC.
- Robert A. Horlick
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES DIRECTED AGAINST LYMPHOCYTE ACTIVATION GENE 3 (LAG-3)
- Publication number 20180127496
- Publication date May 10, 2018
- ANAPTYSBIO, INC.
- Helen Toni JUN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES DIRECTED AGAINST T CELL IMMUNOGLOBULIN AND MUCIN PROTEIN...
- Publication number 20180127500
- Publication date May 10, 2018
- ANAPTYSBIO, INC.
- Marilyn KEHRY
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES DIRECTED AGAINST INTERLEUKIN 36 RECEPTOR (IL-36R)
- Publication number 20180094065
- Publication date Apr 5, 2018
- ANAPTYSBIO, INC.
- Peter BOWERS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES DIRECTED AGAINST PROGRAMMED DEATH-1 (PD-1)
- Publication number 20180051082
- Publication date Feb 22, 2018
- ANAPTYSBIO, INC.
- David J. King
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES DIRECTED AGAINST DISCOIDIN DOMAIN RECEPTOR FAMILY, MEMBE...
- Publication number 20170158762
- Publication date Jun 8, 2017
- ANAPTYSBIO, INC.
- Helen Toni Jun
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES DIRECTED AGAINST INTERLEUKIN-33 (IL-33)
- Publication number 20160333090
- Publication date Nov 17, 2016
- ANAPTYSBIO,INC.
- Robert A. Horlick
- C07 - ORGANIC CHEMISTRY

Please log in for detailed analytics

Trademarklast 30 trademarks

Information Trademark
90663689 - ANAPTYSBIO V
- Serial number 90663689
- Filing date Apr 22, 2021
- AnaptysBio, Inc.
- 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
Information Trademark
87633336 - ANAPTYSBIO
- Serial number 87633336
- Filing date Oct 4, 2017
- AnaptysBio, Inc.
- 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
Information Trademark
87633362 - ANAPTYSBIO V
- Serial number 87633362
- Filing date Oct 4, 2017
- AnaptysBio, Inc.
- 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
Information Trademark
87633456 - ANAPTYSBIO V
- Serial number 87633456
- Registration number 5521178
- Filing date Oct 4, 2017
- AnaptysBio, Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
85537214 - SHM-XEL
- Serial number 85537214
- Filing date Feb 8, 2012
- AnaptsyBio, Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
77978754 - ANAPTYSBIO
- Serial number 77978754
- Registration number 3769268
- Filing date Jun 19, 2008
- AnaptysBio, Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
77503553 - ANAPTYSBIO
- Serial number 77503553
- Filing date Jun 19, 2008
- AnaptysBio, Inc.
- 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
Information Trademark
77417401 - ANAPTYSBIO
- Serial number 77417401
- Filing date Mar 10, 2008
- AnaptysBio, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
77978852 - ANAPTYSBIO
- Serial number 77978852
- Registration number 3779477
- Filing date Mar 10, 2008
- AnaptysBio, Inc.
- 42 - Scientific and technological services and research and design relating thereto

ANAPTYSBIO INC

Organization

Ticker Symbols

Business Address

Mailing Address

State Location

State of Incorporation

Patents Grantslast 30 patents

Method of treating autoimmune disease with antibodies against IL-33

Antibodies directed against T cell immunoglobulin and mucin protein...

Antibodies directed against T Cell immunoglobulin and mucin protein...

Antibodies directed against programmed death-1 (PD-1)

Method of treating pustular psoriasis with antibodies directed agai...

Method of treating inflammatory disorder with antibodies directed a...

Antibodies directed against lymphocyte activation gene 3 (LAG-3)

Antibodies directed against programmed death-1 (PD-1)

Antibodies directed against interleukin 36 receptor (IL-36R)

Antibodies directed against T cell immunoglobulin and mucin protein...

Antibodies directed against interleukin-33 (IL-33) and methods of m...

Antibodies directed against nerve growth factor (NGF)

Antibodies directed against programmed death-1 (PD-1)

Methods of generating libraries and uses thereof

Antibodies directed against IL-17

Methods of generating libraries and uses thereof

Humanized antibodies directed against complement protein C5

Antibodies directed against nerve growth factor (NGF)

Methods of generating libraries and uses thereof

Methods of generating libraries and uses thereof

Patents Applicationslast 30 patents

ANTIBODIES DIRECTED AGAINST INTERLEUKIN-33 (IL-33)

ANTIBODY COMPOSITION

Antibody Agents Directed Against Lymphocyte Activation Gene-3 (LAG-...

ANTI-INTERLEUKIN 36 RECEPTOR (IL-36R) THERAPY FOR HIDRADENITIS SUPP...

Antibodies Directed Against T Cell Immunoglobulin and Mucin Protein...

B AND T LYMPHOCYTE ATTENUATOR (BTLA) MODULATORS AND METHOD OF USING...

Antibodies Directed Against Programmed Death-1(PD-1)

ANTI-INTERLEUKIN 36 RECEPTOR (IL-36R) THERAPY FOR ICHTHYOSIS

PD-1 AGONIST AND METHOD OF USING SAME

ANTIBODIES DIRECTED AGAINST T CELL IMMUNOGLOBULIN AND MUCIN PROTEIN...

ANTIBODY AGENTS DIRECTED AGAINST LYMPHOCYTE ACTIVATION GENE-3 (LAG-...

Antibodies Directed Against Programmed Death-1 (PD-1)

ANTIBODIES DIRECTED AGAINST INTERLEUKIN 36 RECEPTOR (IL-36R)

Antibodies Directed Against Programmed Death-1(PD-1)

Antibodies Directed Against Lymphocyte Activation Gene 3 (LAG-3)

ANTIBODIES DIRECTED AGAINST INTERLEUKIN-33 (IL-33)

ANTI-IL-33 THERAPY FOR ATOPIC DERMATITIS

ANTIBODIES DIRECTED AGAINST T CELL IMMUNOGLOBULIN AND MUCIN PROTEIN...

ANTIBODIES DIRECTED AGAINST INTERLEUKIN 36 RECEPTOR (IL-36R)

ANTIBODIES DIRECTED AGAINST T CELL IMMUNOGLOBULIN AND MUCIN PROTEIN...

ANTIBODIES DIRECTED AGAINST LYMPHOCYTE ACTIVATION GENE 3 (LAG-3)

ANTIBODIES DIRECTED AGAINST PROGRAMMED DEATH- 1 (PD-1)

INHIBITION OF ALLERGIC REACTION USING AN IL-33 INHIBITOR

ANTIBODIES DIRECTED AGAINST INTERLEUKIN-33 (IL-33)

ANTIBODIES DIRECTED AGAINST LYMPHOCYTE ACTIVATION GENE 3 (LAG-3)

ANTIBODIES DIRECTED AGAINST T CELL IMMUNOGLOBULIN AND MUCIN PROTEIN...

ANTIBODIES DIRECTED AGAINST INTERLEUKIN 36 RECEPTOR (IL-36R)

ANTIBODIES DIRECTED AGAINST PROGRAMMED DEATH-1 (PD-1)

ANTIBODIES DIRECTED AGAINST DISCOIDIN DOMAIN RECEPTOR FAMILY, MEMBE...

ANTIBODIES DIRECTED AGAINST INTERLEUKIN-33 (IL-33)

Trademarklast 30 trademarks

90663689 - ANAPTYSBIO V

87633336 - ANAPTYSBIO

87633362 - ANAPTYSBIO V

87633456 - ANAPTYSBIO V

85537214 - SHM-XEL

77978754 - ANAPTYSBIO

77503553 - ANAPTYSBIO

77417401 - ANAPTYSBIO

77978852 - ANAPTYSBIO